Skip to main content

Cannalysis raised $22M to test cannabis products for Vitamin E, but can they close this conversation once and for all?

With billions of dollars pouring into the cannabis industry and the market positioned to grow over 3x by 2022, the emergence of new companies in the space has been ubiquitous. Though this growth has no stopping point in sight, given the ever increasing acceptance of marijuana use nationwide, mainstream media headlines about the perils of “vaping” are making some customers more cautious about their ingestion of the substance.

While many think companies like Juul Labs, creator of the nicotine salt based Juul e-cigarette, are the main problem, a deeper look into the stories of hospitalizations and vape related lung diseases shows that the main problem is the presence and inhalation of Vitamin E acetate oil — a chemical predominantly found in off-brand cannabis vape pens, not necessarily their nicotine based counterparts. This outbreak of vape related lung diseases prompts the need for better testing of products before they hit the shelves, and that is just what the Santa Ana based company Cannalysis seeks to do.

Cannalysis recently raised $22.6M to bring a new testing process for cannabis vape additives to market, their main focus being to test for Vitamin E acetate. The fundraising round was led by CanLab, the largest cannabis testing company in the United States, whose investment was predicated on Cannalysis’ use of robotics and machine learning to speed up their testing process and make it increasingly accurate. Founder and CEO Brian Lannon explains his rationale for building the company, saying

“The big story that’s been going out over the last week isn’t the product that’s going out in cannabis, but an additive called Vitamin E acetate. We have developed a test for that… As part of the different compliance testing that’s required, it’s not mandated to test for any of these additives… What I’m anticipating based on the phone calls we’ve been getting is that a lot of our customers want to get the test to show that they’re not using the stuff.”

As a Business to Business (B2B) company, Cannalysis tests products for other cannabis companies. They track a company’s products through their supply chains and offer data management services to them as well. In addition, Cannalysis has integrated their services with WeedMaps, a centralized database of cannabis dispensaries and products, so end buyers can verify not only the strength of the product they’re buying, but also whether or not there are any additives of which they should be aware. With public worries over vaporizing cannabis products, Cannalysis’ incorporation (and this new investment) comes at a perfect time. I’ll be interested to see what effects this company has on the broader cannabis industry landscape, as well as if they can close the curtain on this discussion of harmful vape additives.

Comments

Popular posts from this blog

AB5 — A Benefit or A Cost?

On September 18th, 2019, California Governor Gavin Newsom signed into law Assembly Bill 5 (AB5) – “arguably the strongest of its kind in the nation,” according to the LA Times . What exactly is this, you may ask? Well, AB5 is a piece of legislation which, “will help reduce worker misclassification – workers being wrongly classified as ‘independent contractors’ rather than employees, which erodes basic worker protections like the minimum wage, paid sick days and health insurance benefits,” says Newsom . Although this sounds all well and good, “gig economy” companies such as Uber, Lyft, Postmates, and the like – companies that take advantage of app-based technology to allow individuals to work on their own time for extra cash – will likely feel the pain of increased regulation on components of their core business models. Threats may arise for these companies, ultimately putting into question the longevity of their businesses. Since these companies identify their workers as independe...

Clayton Christensen - An American Public Intellectual

Abstract In a world that has become increasingly focused on competition and innovation, finding the “next best thing” is a topic often discussed within the startup ecosystem. Founders of new companies strive to find solutions to global problems through the creation of new businesses that hope to fill the void some customers feel in the marketplace. Though innovation is often thought to be focused around business, we all discuss innovative creations in a multitude of spheres — everything from healthcare to politics to education. In this day and age, one can hardly go a single day without hearing the words, “I wish I had a way to do ‘X’.” With a societal philosophy of the grass being greener on the other side (ie. the future), it would be difficult for us to discount the importance of companies that have inserted themselves into our daily lives; these are companies with products we did not know we needed until they became available.  In the startup space, we call these tec...

Inefficiencies in the Market for Innovation (An analysis of barriers to entry for entrepreneurship)

Though entrepreneurship has become increasingly prevalent throughout tech hubs such as Silicon Valley and Los Angeles, the creation of new companies remains hindered by high barriers to entry within the market for innovation. Coming up with a life-changing idea feels nearly impossible, and finding your co-founder as well as new hires is incredibly difficult. To further exacerbate the problem, introductions to venture capitalists are hard to come by, given that investors predominantly focus on companies brought to them by trusted sources. These early connections and decisions could impact the longevity of one’s business, and in turn, the innovation we see in our world. If we can create a network of entrepreneurs who are ready to collaborate and build the companies of the future, the market for innovation would become more efficient, in turn driving more value creation in our world. Entrepreneurship is inherently uncertain, and with uncertainty comes many unknowns. The common view...